Upcoming Events
CE Courses
A Scientific Update of the Treatment of Multiple Sclerosis: Review of AAN 2018 |
 This CME/CNE program will highlight recent advances in the treatment and management of multiple sclerosis (MS) as presented at the 70th Annual American Academy of Neurology Meeting held in Los Angeles, California… Post Conference Review and Analysis |
The New Era of Preventive Cardiology: Applying PCSK9 Inhibitor Therapeutics to Prevent Heart Attack and Stroke |
 This CME/CNE program is derived from content presented at the National Lipid Association 2018 Scientific Sessions in Las Vegas, Nevada… Webcast |
Navigating the Role of PCSK9 Inhibitors in the Prevention of Cardiovascular Events |
 This CME activity will review optimal treatment strategies and recent clinical trial data for patients with dyslipidemia, as presented at the American College of Cardiology 2018 in Orlando, Florida… Webcast |
A Clinical Analysis of Optimal Therapeutics to Improve Outcomes in Patients with Advanced Prostate Cancer |
 This CE program will analyze optimal therapeutics for the treatment and management of prostate cancer patients, incorporating data presented at the the American Society of Clinical Oncology 2018 Genitourinary (GU) Cancers Symposium in San Francisco, California… Post Conference Review and Analysis |
The Role of Oncolytic Viral Therapy in the Management of Patients With Metastatic Melanoma |
 This CME/CE program will delve into the role of oncolytic viral therapy in the treatment and management of the metastatic melanoma patients, highlighting data presented at the Maui and Hawaii Dermatology 2018 annual meetings… Meeting Reporter |
Updated Therapeutic Strategies to Improve Outcomes in Patients with Breast Cancer |
 This CME/CNE program will highlight recent advances in the treatment and management of breast cancer, as presented at the 40th Annual San Antonio Breast Cancer Symposium in San Antonio, Texas… Post Conference Review and Analysis |
PCSK9 Inhibitor Therapeutics 2018: Analyses of Specific Patient Populations Data |
 This educational program will explore and analyze data for PCSK9 inhibitor therapeutics in specific patient populations… Webcast |
The Important Role of Lipoprotein(a) in Cardiovascular Disease: Present and Future Therapeutic Options |
 The content for this activity is derived from a live symposium titled, “The Important Role of Lipoprotein(a) in Cardiovascular Disease: Present and Future Therapeutic Options” presented at the American Heart Association Scientific Sessions 2017 in Anaheim, California… Webcast |
Applying Individualized Therapeutic Strategies of Switching and Sequencing to Improve Outcomes for Patients With Multiple Sclerosis |
 This content is derived from a CME symposium held in conjunction with the Advanced Curriculum for Multiple Sclerosis 2018 in San Diego, California… Webcast |
Novel Therapeutics in the Treatment and Management of Multiple Myeloma at ASH 2017 |
 This CME/CNE program will discuss recent advances in the treatment and management of multiple myeloma (MM) as presented at the American Society of Hematology 59th Annual Meeting & Exposition in Atlanta, Georgia… Post Conference Review and Analysis |
Clinical Updates on Disease Modifying Therapies to Improve Outcomes for Patients with Multiple Sclerosis |
 This educational activity will feature content presented at the MS Paris 2017 7th Joint ECTRIMS-ACTRIMS Meeting in Paris, France… Meeting Reporter |
Best Practices to Apply JAK Inhibitors for the Management of Patients With Polycythemia Vera |
 This CME program will highlight recent scientific advances in the treatment and management of patients with polycythemia vera (PV) presented at the American Society of Hematology 59th Annual Meeting & Exposition in Atlanta, Georgia… Post Conference Review and Analysis |